Cardio Diagnostics Holdings, Inc. CDIO

1.95 0.04 2.09% as of 25 Sep
Market cap
$5.7M
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '17
P/E ratio
0.00 0.00 0.00 0.00 0.00 —
P/S ratio
318.47 706.27 0.00 0.00 0.00 —
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 —
P/Operating CF
(3.48) (17.70) (23.00) (1.09) (7,957.53) —
P/B ratio
0.68 2.58 13.11 0.79 3,506.12 —
Price to Tangible BV
0.68 2.58 13.20 0.80 3,506.12 —
EV/Sales
(24.52) 481.99 0.00 0.00 0.00 —
EV/EBITDA
0.06 0.00 0.00 0.16 0.00 —
EV/Operating CF
0.06 (3.37) (6.61) 0.14 0.00 —
EV/FCF
0.06 (3.23) (6.00) 0.14 0.00 —
Quick Ratio
8.46 12.42 1.53 2.11 15.15 —
Current Ratio
9.79 13.92 3.29 3.02 23.70 —
Net Debt/EBITDA
0.84 0.97 0.18 0.91 0.85 —
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 —
Asset Turnover
0.00 0.00 0.00 0.00 0.00 —
Operating CF/Net income
0.88 0.60 0.68 1.09 0.94 —
Capex/Depreciation
(0.47) (0.78) (5.16) 0.00 0.00 —
Interest Coverage
0.00 0.00 0.00 0.00 0.00 —
ROE
(78.62%) (133.97%) (230.77%) (173.60%) 0.00% —
ROA
(70.70%) (111.20%) (156.40%) (126.80%) (112.60%) —
ROIC
(217.55%) (302.18%) (270.31%) (1,543.33%) (69.83%) —
Return on Tangible Assets
(108.02%) (94.92%) (335.54%) (118.36%) (80.61%) —
Average Days of Receivables
199.76 194.53 106.73 0.00 365.00 —
Research and Development Expense of Revenue
4,332.43% 653.30% 849.12% 4,040.00% 3,500.00% —
Selling, General and Administrative Expense of Revenue
39,138.51% 23,361.32% 41,492.40% 449,300.00% 63,766.67% —
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.01 0.05 0.00
Share Based Compensation of Revenue
744.59% 7,424.64% 7,481.29% 0.00% 6,666.67% —
Graham Net Nets
1.08 0.31 0.03 1.16 (0.03) —
Graham Number
0.00 0.00 0.00 0.00 0.00 —
Earnings Yield
(137.27%) (34.90%) (21.50%) (137.37%) (3.97%) —
Free Cash Flow Yield
(124.63%) (21.13%) (16.11%) (150.07%) 0.00% —
Revenue per Share
0.01 0.04 0.04 0.01 0.02 —
Operating CF per Share
(3.27) (5.57) (13.43) (49.52) (15.12) —
Capex per Share
(0.11) (0.24) (1.36) 0.00 0.00 —
Free Cash Flow per Share
(3.38) (5.81) (14.79) (49.52) (15.12) —
Cash per Share
2.92 8.74 3.04 40.05 13.25 —
Shareholders Equity per Share
3.98 10.67 7.00 41.85 27.60 —
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 —
Book value per Share
3.98 10.67 7.00 41.85 27.60 —
Free Cash Flow
(5.91) (5.21) (6.25) (5.09) (0.59) —
Working Capital
5.32 8.16 1.92 3.94 0.77 —
Capital Expenditures
(0.19) (0.21) (0.58) (0.08) (0.11) —
Net Current Asset Value
5.13 7.73 1.26 3.94 0.77 —
EV/EBIT
0.06 0.00 0.00 0.16 0.00 —
Capex to Sales
12.66 6.15 33.67 0.00 0.00 —
Net Profit Margin
(43,906.76%) (24,021.49%) (48,987.13%) (466,100.00%) (68,933.33%) —
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 —
Other line items
Depreciation/Fixed assets
0.57 0.41 0.20 0.00 0.00 —
Cash ROIC
(53.19%) (32.59%) (147.21%) (60.47%) (37.02%) —
Accounts Receivable Turnover
1.11 2.96 5.80 0.00 0.00 —
Accounts Payable Turnover
0.00 0.00 0.00 0.00 — —
Inventory Turnover
— — — 0.00 — —
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 —
Days of Inventory on Hand
— — — 0.00 — —
Average Receivables
0.01 0.01 0.00 — — —
Average Payables
0.09 0.17 0.67 0.57 — —
Average Assets
9.19 7.54 5.36 3.68 0.55 —
Average Common Equity
8.27 6.26 3.63 2.68 — —

Fold the line items

Columns are period end dates